Health and social work services

Tender description

North of England Commissioning Support (NECS) is a commissioning support service hosted by NHS England and is managing a future procurement process for the provision of a Diabetic Eye Screening Programme in Greater Manchester for and on behalf of Greater Manchester Health & Social Care Partnership (the Commissioner). The Commissioner is issuing this notice to alert and pre-notify the market of this future tender opportunity for Diabetic Eye Screening Programme in Greater Manchester covering 2 Lots: Lot 1 Greater Manchester North estimated annual value 2 200 000 GBP x 3 years + 1 year Lot 2 Greater Manchester South estimated annual value 2 200 000 GBP x 3 years + 1 year. The Commissioner is issuing this notice to alert and pre-notify the market of this future tender opportunity for Diabetic Eye Screening Programme in Greater Manchester North. The aim of the service is to reduce the risk of sight loss amongst people with diabetes by the prompt identification and effective treatment if necessary of sight threatening diabetic retinopathy, at the appropriate stage during the disease process. This will be achieved by delivering evidence-based,and population-based screening programmes that: — identify the eligible population and ensure effective delivery with maximum coverage — are safe, effective, of a high quality, externally and independently monitored, and quality assured — lead to earlier detection, appropriate referral, effective treatment and improved outcomes — are delivered and supported by suitably trained, competent, and qualified, clinical and non-clinical staff who, where relevant, participate in recognised on-going Continuing Medical Education (CME), Continuous Professional Development (CPD), and Quality Assurance (QA) schemes — have audit embedded in the service. The Commissioner is issuing this notice to alert and pre-notify the market of this future tender opportunity for Diabetic Eye Screening Programme in Greater Manchester The aim of the service is to reduce the risk of sight loss amongst people with diabetes by the prompt identification and effective treatment if necessary of sight threatening diabetic retinopathy, at the appropriate stage during the disease process. This will be achieved by delivering evidence-based, and population-based screening programmes that: — identify the eligible population and ensure effective delivery with maximum coverage — are safe, effective, of a high quality, externally and independently monitored, and quality assured — lead to earlier detection, appropriate referral, effective treatment and improved outcomes — are delivered and supported by suitably trained, competent, and qualified, clinical and non-clinical staff who, where relevant, participate in recognised on-going Continuing Medical Education (CME), Continuous Professional Development (CPD), and Quality Assurance (QA) schemes — have audit embedded in the service.